Eugene Kennedy
Hoofd Techniek/Wetenschap/O&O bij CARISMA THERAPEUTICS, INC.
Vermogen: - $ op 30-04-2024
Actieve functies van Eugene Kennedy
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CARISMA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 02-05-2024 | - |
Loopbaan van Eugene Kennedy
Eerdere bekende functies van Eugene Kennedy
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| GALERA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-09-2022 | 01-09-2023 |
| LUMOS PHARMA, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2014 | 06-03-2021 |
| Thomas Jefferson University | Corporate Officer/Principal | 01-01-2006 | 01-12-2013 |
| Innovative Cellular Therapeutics, Inc. | Hoofd Techniek/Wetenschap/O&O | - | - |
The Hope Funds for Cancer Research
 The Hope Funds for Cancer Research Miscellaneous Commercial ServicesCommercial Services The Hope Funds for Cancer Research provides funds for cancer research. The private company is based in Newport, RI. The company was founded by Leah Rush Cann. | Directeur/Bestuurslid | - | - |
| LUMOS PHARMA, INC. | Hoofd Techniek/Wetenschap/O&O | 14-11-2017 | - |
Opleiding van Eugene Kennedy
| University of Virginia | Undergraduate Degree |
| Medical College of Virginia | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 10 |
Operationeel
| Chief Tech/Sci/R&D Officer | 5 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| GALERA THERAPEUTICS, INC. | Health Technology |
| LUMOS PHARMA, INC. | Health Technology |
| CARISMA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
NewLink Genetics Corp.
 NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology NewLink Genetics Corp. is a late-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of novel immunotherapeutic products to improve cancer treatment options for patients and physicians. The firm's portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a range of oncology indications. It products include HyperAcute Pancreas, HyperAcute Lung, HyperAcute Melanoma, HyperAcute Imunotherapies, NLG8189, and IDO Pathway Inhibitors. The company was founded by Charles J. Link and Nicholas N. Vahanian on June 4, 1999 and is headquartered in Ames, IA. | Health Technology |
The Hope Funds for Cancer Research
The Hope Funds for Cancer Research Miscellaneous Commercial ServicesCommercial Services The Hope Funds for Cancer Research provides funds for cancer research. The private company is based in Newport, RI. The company was founded by Leah Rush Cann. | Commercial Services |
| Innovative Cellular Therapeutics, Inc. |
- Beurs
- Insiders
- Eugene Kennedy
- Ervaring